Komori
Pharma Foods International (2929) · InitiativeAdvanced

Talent Acquisition and Organisational Strengthening

First written in FY2021. 4 of 6 entries say "Advanced", first in FY2022-Q1. Latest entry: FY2024.

6entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2022-Q1 – FY2023RestatedFY2024-Q12021: 220212022: 120222023: 220232024: 12024
Same theme, other companies
Securing and developing outstanding talentA theme 984 companies write about · 42 as a headwind · 1027 as a tailwind

108 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 179 companies compared. The sentences above are computed from all 179.Comparing 200 of the theme's 1069 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「Under the creation of the "New Organization," we will develop systems and programs that enable employees to work with confidence and grow, based on the belief that "people support creative business activities." Through the formation of an HR project team and the active use of M&A and alliances, we are building a global organizational structure in which talent can thrive regardless of age, gender or nationality.」

    For the creation of the New Organization, the company is building a global organizational structure by combining an HR project team, development of systems and programs, and M&A and alliances.
  2. FY2024-Q1RestatedAnnual report

    「To meet these needs, we established the theme of the Medium-Term Management Plan 2026, the "New Value Creation 1K Project," and focused on R&D investment, development of new products and development of sales channels, and strengthening the organizational structure to achieve it.」

    The company continues to strengthen its organizational structure as one means of achieving the medium-term management plan.
  3. FY2023AdvancedAnnual report

    「Under the creation of the "New Organization," we will develop systems and programs that enable employees to work with confidence and grow, based on the belief that "people support creative business activities."」

    As part of the creation of the New Organization, the company advanced the establishment of an HR project team and various systems and programs, reaching a structure of 670 employees, including 82 R&D staff.
  4. FY2022AdvancedAnnual report

    「The Group regards R&D as its top priority in developing its business and conducts R&D with 71 staff, including 19 PhDs, out of a total workforce of 624 (as of 31 July 2022).」

    The group now has 624 employees, including 71 R&D staff, indicating an expansion of its R&D workforce.
  5. FY2022-Q1AdvancedAnnual report

    「To meet these needs and achieve the theme of the medium-term management plan, “Creating New Value,” the Group actively invested in R&D in its functional materials and biomedical businesses, with particular emphasis on strengthening the recruitment of R&D personnel.」

    The company is strengthening recruitment of research and development personnel and advancing the strengthening of its R&D structure to support business expansion.
  6. FY2021First statedAnnual report

    「Regardless of age, gender or nationality, we will evaluate and develop employees based on motivation and ability, with the aim of building a robust organizational structure. We will also actively recruit outstanding and globally minded talent.」

    The company identified evaluation and development based on motivation and ability, together with the recruitment of outstanding and global talent, as priorities for the personnel supporting business expansion.
Moved together

"Development of antibody therapeutics using proprietary chicken antibody technology" moved the same way as this thread, in the same document, in 4 of its 6 moves.

444444★123456
  1. ★This thread
  2. 1Development of antibody therapeutics using proprietary chicken antibody technology4×
  3. 2Research and Development Expenditure4×
  4. 3Raising Working Capital through Borrowings4×
  5. 4Policy of Making Research and Development the Top Priority4×
  6. 5Expanding Enterprise Value Through the Active Pursuit of M&A4×
  7. 6SDG Initiatives Through the Upcycling of Underutilized Resources4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Pharma Foods International yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.